Dorothee Foernzler

1.9k citations

20 papers · 1.6k indexed · 1 hit paper · h-index 12

Co-authors: David R. Beier Nancy C. Andrews William F. Dietrich Mark D. Fleming Cameron C. Trenor Maureen A. Su Annick Thompson John D. McPherson
Topics: Lung Cancer Treatments and Mutations (5 papers)Colorectal Cancer Treatments and Studies (3 papers)Lung Cancer Research Studies (3 papers)
Cited by: Hematology Nutrition and Dietetics Genetics
Journals: Science Nature Genetics Journal of Clinical Oncology
Partner nations: United States Switzerland Germany

In The Last Decade

Dorothee Foernzler

19 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene

1997 975 citations Mark D. Fleming, Cameron C. Trenor et al. Nature Genetics profile →

Peers

Countries citing papers authored by Dorothee Foernzler

Since Specialization

Citations

This map shows the geographic impact of Dorothee Foernzler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothee Foernzler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothee Foernzler more than expected).

Fields of papers citing papers by Dorothee Foernzler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorothee Foernzler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothee Foernzler. The network helps show where Dorothee Foernzler may publish in the future.

Co-authorship network of co-authors of Dorothee Foernzler

This figure shows the co-authorship network connecting the top 25 collaborators of Dorothee Foernzler. A scholar is included among the top collaborators of Dorothee Foernzler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothee Foernzler. Dorothee Foernzler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of Two Illumina Whole Transcriptome RNA Sequencing Library Preparation Methods Using Human Cancer FFPE Specimens 2022 ·Technology in Cancer Research & Treatment ·(unknown),P. Alexander Rolfe,Dorothee Foernzler,(unknown),Sheng Zhao,(unknown),(unknown)	8
2	16LBA VEGFR-1 polymorphisms as potential predictors of clinical outcome in bevacizumab-treated patients with metastatic pancreatic cancer 2009 ·European Journal of Cancer Supplements ·Diether Lambrechts,Paul Delmar,Ian Buysschaert,Bart Claes,Betül T. Yesilyurt,Chris Verslype,Dorothee Foernzler,Peter Carmeliet,(unknown),Eric Van Cutsem	10
3	Genetic Polymorphism ofCYP2C19Gene in the Stanislas Cohort. A link with Inflammation 2008 ·Annals of Human Genetics ·(unknown),Hind Berrahmoune,Annick Thompson,(unknown),Suzanne Droesch,Gérard Siest,Dorothee Foernzler,Sophie Visvikis‐Siest	32
4	A Phase II Pharmacodynamic Study of Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy 2008 ·Clinical Cancer Research ·Enriqueta Felip,Federico Rojo,Martin Reck,(unknown),Barbara Klughammer,(unknown),S. Cedrés,Sergio Peralta,Heiko Maacke,Dorothee Foernzler,Marta Parera,Joachim Möcks,Cristina Saura,U. Gatzemeier,José Baselga	68
5	Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort 2006 ·Journal of Hypertension ·Nicolas Gambier,Jean‐Brice Marteau,Anne‐Marie Batt,(unknown),Annick Thompson,Gérard Siest,Dorothee Foernzler,Sophie Visvikis‐Siest	20
6	P-949 Phase II pharmacodynamic trial of erlotinib in advancednon-small cell lung cancer (NSCLC) patients previously treated with platinum-based chemotherapy 2005 ·Lung Cancer ·Enriqueta Felip,Federico Rojo,(unknown),Dorothee Foernzler,Joaquim Majó Fernández,Barbara Klughammer,Jorge Ramos,Heiko Maacke,U. Brennscheidt,José Baselga	1
7	Exploratory analyses EGFR, kRAS mutations and other molecular markers in tumors of NSCLC patients (pts) treated with chemotherapy +/- erlotinib (TALENT) 2005 ·Journal of Clinical Oncology ·U. Gatzemeier,(unknown),Dorothee Foernzler,Joachim Moecks,(unknown),Francesca Rosa,Guido Sauter,U. Brennscheidt	39
8	Molecular genetics of pseudoxanthoma elasticum: type and frequency of mutations inABCC6 2005 ·Human Mutation ·(unknown),Amanda L. Lumsden,Ulf P. Guenther,Dorothee Foernzler,Stéphanie Christen-Zäch,(unknown),Raj Ramesar,Mark Lebwohl,Daniel Hohl,Kenneth H. Neldner,Klaus Lindpaintner,Robert I. Richards,Berthold Struk	75
9	Phase II pharmacodynamic trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients previously treated with platinum-based chemotherapy: preliminary results 2005 ·Journal of Clinical Oncology ·(unknown),Federico Rojo,(unknown),Dorothee Foernzler,(unknown),Barbara Klughammer,(unknown),Heiko Maacke,U. Brennscheidt,José Baselga	1
10	PD-155 Molecular markers such as EGFR and kRAS mutations aspredictors of sensitivity to erlotinib in patients (pts) with NSCLC: Exploratory subanalyses of TALENT, a phase III trial 2005 ·Lung Cancer ·Martin Reck,(unknown),Dorothee Foernzler,Joachim Moecks,(unknown),Francesca Rosa,Guido Sauter,U. Brennscheidt,U. Gatzemeier	2
11	In Silico Genetics: Identification of a Functional Element Regulating H2 - E α Gene Expression 2004 ·Science ·Guochun Liao,Jianmei Wang,(unknown),John Allard,Janet Cheng,(unknown),Steven L. Shafer,Anne Puech,John D. McPherson,Dorothee Foernzler,Gary Peltz,Jonathan Usuka	89
12	A defect in a novel ADAMTS family member is the cause of the belted white-spotting mutation 2003 ·Development ·(unknown),Dorothee Foernzler,Stacie K. Loftus,Shanming Liu,John D. McPherson,(unknown),Suneel Apte,William J. Pavan,David R. Beier	63
13	Lack of association between the SOST gene and bone mineral density in perimenopausal women: analysis of five polymorphisms 2002 ·Bone ·Wendy Balemans,Dorothee Foernzler,(unknown),Martin Ebeling,Annick Thompson,David M. Reid,Klaus Lindpaintner,Stuart H. Ralston,Wim Van Hul	35
14	Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity 2002 ·The Pharmacogenomics Journal ·Gonzalo Acuña,Dorothee Foernzler,Diane U. Leong,Michael Rabbia,(unknown),Ernest Dorflinger,Rodolfo Gasser,Josephine Hoh,Jürg Ott,Edilio Borroni,(unknown),Annick Thompson,Jia Li,L. Hashimoto,Klaus Lindpaintner	57
15	A semi-automated system for analysis and storage of SNPs 2001 ·Human Mutation ·Valerie Lehnert,James A. Holzwarth,Michael Ott,Annick Thompson,(unknown),Dorothee Foernzler	6
16	Nontruncating APC germ-line mutations and mismatch repair deficiency play a minor role in APC mutation-negative polyposis 2001 ·PubMed ·Karl Heinimann,Annick Thompson,(unknown),(unknown),(unknown),(unknown),Rémy Meier,Kimberly Walter,Peter Bauerfeind,(unknown),Hansjakob Müller,Dorothee Foernzler,Zuzana Dobbie	42
17	The spontaneous coat color mutant white nose ( wn ) maps to murine Chromosome 15 1999 ·Mammalian Genome ·Peter Marks,(unknown),Dar-Bin Shieh,Dorothee Foernzler,David R. Beier,(unknown)	2
18	Isolation of Zebrafish gdf7 and Comparative Genetic Mapping of Genes Belonging to the Growth/Differentiation Factor 5, 6, 7 Subgroup of the TGF-β Superfamily 1999 ·Genome Research ·Alan J. Davidson,John H. Postlethwait,Yi‐Lin Yan,David R. Beier,(unknown),Dorothee Foernzler,Anthony Celeste,Kathryn E. Crosier,Philip S. Crosier	25
19	Chapter 11 Gene Mapping in Zebrafish Using Single-Strand Conformation Polymorphism Analysis 1998 ·Methods in cell biology ·Dorothee Foernzler,David R. Beier	3
20	Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter genebreakdown → 1997 ·Nature Genetics ·Mark D. Fleming,Cameron C. Trenor,Maureen A. Su,Dorothee Foernzler,David R. Beier,William F. Dietrich,Nancy C. Andrews	975

About Dorothee Foernzler

Dorothee Foernzler is a scholar working on Biochemistry, Oncology and Cell Biology, having authored 20 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Hematology (797 citations), Nutrition and Dietetics (721 citations) and Genetics (466 citations). Dorothee Foernzler has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include David R. Beier, Nancy C. Andrews, William F. Dietrich, Mark D. Fleming, Cameron C. Trenor, Maureen A. Su, Annick Thompson, John D. McPherson, U. Gatzemeier and Klaus Lindpaintner. Their work appears in journals such as Science, Nature Genetics and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact